BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mravinacova S, Jönsson M, Christ W, Klingström J, Yousef J, Hellström C, Hedhammar M, Havervall S, Thålin C, Pin E, Tegel H, Nilsson P, Månberg A, Hober S. A cell-free high throughput assay for assessment of SARS-CoV-2 neutralizing antibodies. N Biotechnol 2021;66:46-52. [PMID: 34628049 DOI: 10.1016/j.nbt.2021.10.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Yao X, Zhang Z, Mei Q, Li S, Xing L, Long Y, Zhang D, Wang J, Wang X, Xie B, Yang B, Gao Y, Wu C, Meng Q. A highly sensitive bead-based flow cytometric competitive binding assay to detect SARS-CoV-2 neutralizing antibody activity. Front Immunol 2022;13:1041860. [PMID: 36532082 DOI: 10.3389/fimmu.2022.1041860] [Reference Citation Analysis]
2 Rando HM, Brueffer C, Lordan R, Dattoli AA, Manheim D, Meyer JG, Mundo AI, Perrin D, Mai D, Wellhausen N, Consortium CR, Gitter A, Greene CS. Molecular and Serologic Diagnostic Technologies for SARS-CoV-2. ArXiv 2022. [PMID: 35547240] [Reference Citation Analysis]
3 Meyrath M, Szpakowska M, Plesseria J, Domingues O, Langlet J, Weber B, Krüger R, Ollert M, Chevigné A. Nanoluciferase-based cell fusion assay for rapid and high-throughput assessment of SARS-CoV-2-neutralizing antibodies in patient samples. Methods in Enzymology 2022. [DOI: 10.1016/bs.mie.2022.07.015] [Reference Citation Analysis]